SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Orchid BioSciences, Inc ORCH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rich987 who wrote (63)11/25/2003 10:06:31 AM
From: Skywatcher   of 94
 
and then!!!! we get a hit on ORCH
Orchid Cellmark Awarded FBI Contracts to
Develop SNP Technology for Advanced Forensic
Applications
Tuesday November 25, 7:00 am ET

PRINCETON, N.J., Nov. 25 /PRNewswire-FirstCall/ -- Orchid BioSciences, Inc. (Nasdaq:
ORCH - News) today announced that its Orchid Cellmark unit was awarded two
contracts from the U.S. Federal Bureau of Investigation to develop specific aspects of
the Company's SNP technology for additional forensic DNA testing applications. The
goal of the two contracts is to develop new forensic tools that will increase the ability of
investigators to identify individuals using DNA samples that have degraded and
therefore contain a limited amount of genetic material. Work on both of these contracts
is being undertaken in Orchid Cellmark's Dallas facility and is expected to be completed
in about one year.

CC
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News